Advertisement
Screener

COCRYSTAL PHARMA, INC. (COCP) Increase (Decrease) in Due to Officers and Stockholders

2.8 / 5 stars · 68/120 Roast Me

COCRYSTAL PHARMA, INC. Increase (Decrease) in Due to Officers and Stockholders

COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Due to Officers and Stockholders of -$1.14 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders · last filed 2016-11-09

  • COCRYSTAL PHARMA, INC. increase (decrease) in due to officers and stockholders for the quarter ending 2016-09-30 was -$1.14M.
Period endIncrease (Decrease) in Due to Officers and Stockholders 3 monthIncrease (Decrease) in Due to Officers and Stockholders 9 month
2016-09-30-$1.14M
10-Q · filed 2016-11-09
$299.00K
10-Q · filed 2016-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Rocket One Inc. (RKTO)United States$0.019B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62